A new variant of genetically modified immune T cell (HLA-independent T cell receptors) that can attack cancer was developed at the Memorial Sloan Kettering (MSK) Cancer Center. It was developed by genetically modifying an individual’s immune T cells and decking them up with special receptors that can detect cancer in the body.
Prof. Dr. Dattatreyudu Nori is a world-renowned Indian radiation oncologist. He was the principal investigator for numerous clinical trials sponsored by the National Cancer Institute and has received countless national and international awards including the Distinguished Alumnus Award of the Memorial Sloan-Kettering Cancer Center Alumni Society.
Dr. Dattatreyudu Nori – A Radiant Light for the Dark World of Cancer Read More »
Comprehensive Genomic Profiling (CGP) can analyze a broad panel of genes with a single test to detect genomic alterations that are known to propel cancer growth, for example, base substitutions, insertions, deletions, Copy Number Alterations (CNAs), and rearrangements or fusions.
Comprehensive Genomic Profiling for Cancer Read More »
Cancer treatments usually target cancer that has developed in a specific organ or tissue, like breast or lung cancer. Tumour-agnostic therapy, also known as tissue-agnostic therapy, utilizes the same drug to treat all cancer types that have certain genetic mutations or biomarkers that are targeted by the drug.
Approved Tumour-Agnostic Drugs Read More »
One question asked by the audience to Dr. Samatha was, “What is the possibility of preventing a lot of diseases using predictive and preventive medicine and using metabolic biomarkers at a very early stage for a lot of cases since the cost of tests after getting a disease is very expensive
Dr. Hima started the second panel discussion by thanking all the panelists for gracing the stage and accepting the invitation to come over and talk a little bit about personalized medicine. She introduced all the physicians who have been actively incorporating personalized medicine into their practice and saw what their perspective was on the floor and what was happening right now.
Panel Discussion: 2 -Realizing the Promise of Personalized Medicine Read More »
A recent study identified GATA4 and MYH6 as the potential risk genes responsible for septal defects in congenital heart disease. The results of this study were published in the journal, Gene.
High-risk genes responsible for septal defects in congenital heart disease identified Read More »
A recent study illustrated that the same genotype can give rise to a biphasic phenotype in the same person or a reverse phenotype in someone from the same family in monogenic cases with hyperinsulinism. The results of this study were published in Reviews in Endocrine and Metabolic Disorders.
Hyperinsulinism is associated with a family history of monogenic diabetes Read More »
A recent study revealed new biology of abdominal aortic diameter (AAD)…
Genetic locus associated with the infrarenal aortic aorta found Read More »
A recent study suggests that drug-gene pairs in anti-hypertensive…
Drug-gene pairs in anti-hypertensive treatment improves patient care Read More »
A brand name of Uppaluri K&H Personalized Medicine Clinic Private Limited.
Cracking the ‘One Size Fits All’ theory of medical science while inculcating the philosophy of “You are unique, and so should your medical treatment…”
Address :
Suit#2B Plot No.240,Nirvana, Road No. 36, Jawahar Nagar, Jubilee Hills, Hyderabad, Telangana 500033, India